Send us a text

Neil Klompas, CPA, CA is President, Chief Executive Officer, and Director of Augurex ( https://augurex.com/ ), a leading edge diagnostic company focused on developing and commercializing advanced diagnostics with the aim of improving patient outcomes and ending diagnostic delays in autoimmune conditions.
Mr. Klompas has been involved in healthcare and biotechnology for over 30 years in various senior leadership roles spanning operational, financial and research and development responsibilities. Most recently, he served as President and Chief Operating Officer of Zymeworks (NASDAQ: ZYME), where he had previously held the role of Chief Financial Officer.
Prior to that, Mr. Klompas’ experience included roles with KPMG, a global financial services firm, in both the United States and Canada where he advised on transactions and financial engagements across the pharmaceuticals, biotechnology and medical devices sectors.
Mr. Klompas serves as a director on the boards of InMed Pharmaceuticals (NASDAQ; INM), NervGen Pharma (TSXV; NGEN), and HTuO Biosciences. He has previously served as a director and advisor to various biotechnology companies, including previously serving on the boards of Ovensa Inc., and Liminal Biotherapeutics.
Mr. Klompas holds a Bachelor of Science degree from the University of British Columbia, and is a Chartered Accountant and Chartered Professional Accountant.
#NeilKlompas #Augurex #AutoimmuneConditions #Diagnostics #AxialSpondyloarthritis #axSpA #ChronicInflammatoryDisease #AnkylosingSpondylitis #BackPain #1433ηEtaProtein #Anti1433EtaAutoantibody #SPINEstat #JOINTstat
#ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #STEM #Innovation #Technology #Science #Research

Support the show